These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 20627920
1. Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma. Gelb AF, George SC, Silkoff PE, Krishnan A, Fraser C, Taylor CF, Shinar CM, Maginot T. Thorax; 2010 Jul; 65(7):619-25. PubMed ID: 20627920 [Abstract] [Full Text] [Related]
2. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Gelb AF, Taylor CF, Nussbaum E, Gutierrez C, Schein A, Shinar CM, Schein MJ, Epstein JD, Zamel N. Am J Respir Crit Care Med; 2004 Oct 01; 170(7):737-41. PubMed ID: 15229098 [Abstract] [Full Text] [Related]
3. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma. Prieto L, Gutiérrez V, Pérez-Francés C, Badiola C, Lanuza A, Bruno L, Ferrer A. Ann Allergy Asthma Immunol; 2005 Nov 01; 95(5):452-61. PubMed ID: 16312168 [Abstract] [Full Text] [Related]
4. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M. Eur Respir J; 2010 Jun 01; 35(6):1221-7. PubMed ID: 19996191 [Abstract] [Full Text] [Related]
5. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg. Gelb AF, Taylor CF, Simmons M, Shinar C. Pulm Pharmacol Ther; 2009 Dec 01; 22(6):516-21. PubMed ID: 19467341 [Abstract] [Full Text] [Related]
6. Airway diffusing capacity of nitric oxide and steroid therapy in asthma. Shin HW, Rose-Gottron CM, Cooper DM, Newcomb RL, George SC. J Appl Physiol (1985); 2004 Jan 01; 96(1):65-75. PubMed ID: 12959957 [Abstract] [Full Text] [Related]
7. In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid. Gelb AF, Moridzadeh R, Singh DH, Fraser C, George SC. J Allergy Clin Immunol; 2012 Jun 01; 129(6):1491-8. PubMed ID: 22560478 [Abstract] [Full Text] [Related]
8. Airway nitric oxide output is reduced in bronchiectasis. Foley SC, Hopkins NO, Fitzgerald MX, Donnelly SC, McLoughlin P. Respir Med; 2007 Jul 01; 101(7):1549-55. PubMed ID: 17234397 [Abstract] [Full Text] [Related]
9. Reversal of the late asthmatic response increases exhaled nitric oxide. Boot JD, Tarasevych S, Sterk PJ, Schoemaker RC, Wang L, Amin D, Cohen AF, Diamant Z. Respir Med; 2005 Dec 01; 99(12):1591-4. PubMed ID: 15878654 [No Abstract] [Full Text] [Related]
10. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Fardon T, Haggart K, Lee DK, Lipworth BJ. Respir Med; 2007 Jun 01; 101(6):1218-28. PubMed ID: 17178217 [Abstract] [Full Text] [Related]
11. Association of exhaled nitric oxide to asthma burden in asthmatics on inhaled corticosteroids. Zeiger RS, Schatz M, Zhang F, Crawford WW, Kaplan MS, Roth RM, Chen W. J Asthma; 2011 Feb 01; 48(1):8-17. PubMed ID: 21155706 [Abstract] [Full Text] [Related]
12. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. McCurdy MR, Sharafkhaneh A, Abdel-Monem H, Rojo J, Tittel FK. J Breath Res; 2011 Mar 01; 5(1):016003. PubMed ID: 21378438 [Abstract] [Full Text] [Related]
13. Comparison of the effects of nebulized terbutaline with or without intravenous betamethasone on exhaled nitric oxide in children with acute asthma attack. Lee MY, Tsai YG, Yang KD, Hung CH. J Microbiol Immunol Infect; 2006 Feb 01; 39(1):33-8. PubMed ID: 16440121 [Abstract] [Full Text] [Related]
15. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM. J Allergy Clin Immunol; 2005 Feb 01; 115(2):233-42. PubMed ID: 15696076 [Abstract] [Full Text] [Related]
16. Different patterns of exhaled nitric oxide response to β2-agonists in asthmatic patients according to the site of bronchodilation. Michils A, Malinovschi A, Haccuria A, Michiels S, Van Muylem A. J Allergy Clin Immunol; 2016 Mar 01; 137(3):806-12. PubMed ID: 26688519 [Abstract] [Full Text] [Related]
17. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma. Chanez P, Stallaert R, Reznikova E, Bloemen P, Adamek L, Joos G. Respir Med; 2010 Aug 01; 104(8):1101-9. PubMed ID: 20452196 [Abstract] [Full Text] [Related]
18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
19. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Yasui H, Fujisawa T, Inui N, Kato M, Hashimoto D, Enomoto N, Nakamura Y, Shirai T, Suda T, Nakamura H, Chida K. Respir Med; 2012 Apr 01; 106(4):508-14. PubMed ID: 22265857 [Abstract] [Full Text] [Related]
20. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. Respir Med; 2009 Feb 01; 103(2):296-300. PubMed ID: 18805684 [Abstract] [Full Text] [Related] Page: [Next] [New Search]